Michael Peck, MD
Vascular Surgery · San Antonio, TXNPI 1235217241
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,713 of the $9,717 with a category attached, or 79.4%. 34 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 24.4% of the total. Reporting peaked in 2023 at $2,270 and has fallen 62.8% since, to $845 in 2025.
Across 247 payments — averaging $39.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$2K
- Bard Peripheral Vascular, Inc.$906
- Inari Medical, Inc.$894
- Johnson & Johnson$831
- Philips North America LLC$745
- Silk Road Medical, Inc.$554
- plus $3K from 28 others
What the payments were for
- Travel & lodging$2,00321%
- Food & beverage$7,71379%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 15 | $2,375 |
| Bard Peripheral Vascular, Inc. | 42 | $906 |
| Inari Medical, Inc. | 8 | $894 |
| Johnson & Johnson | 37 | $831 |
| Philips North America LLC | 37 | $745 |
| Silk Road Medical, Inc. | 9 | $554 |
| Endologix LLC | 4 | $501 |
| Bolton Medical Inc | 8 | $355 |
| Medtronic(2 entities) | 11 | $315 |
| Angiodynamics, Inc. | 9 | $281 |
| Cook Medical LLC | 11 | $250 |
| Boston Scientific | 9 | $207 |
| Stryker | 2 | $192 |
| Shape Memory Medical Inc. | 1 | $148 |
| Bsn Medical Inc | 2 | $128 |
| Heron Therapeutics, Inc. | 1 | $125 |
| AbbVie | 6 | $116 |
| Shockwave Medical, Inc | 1 | $110 |
| Tactile Systems Technology Inc | 7 | $90 |
| Cardiva Medical, Inc. | 4 | $86 |
| Acist Medical Systems, Inc. | 1 | $77 |
| Lemaitre Vascular, Inc. | 3 | $62 |
| Abbott | 2 | $55 |
| BD | 2 | $41 |
| Surmodics, Inc. | 2 | $39 |
| Baxter Healthcare | 2 | $39 |
| Acera Surgical, Inc. | 2 | $38 |
| Convatec Inc. | 2 | $36 |
| Medline Industries LP | 2 | $27 |
| Siemens Medical Solutions USA, Inc. | 1 | $23 |
| Kerecis Limited | 1 | $22 |
| Portola Pharmaceuticals, LLC | 1 | $20 |
| Biotronik Inc. | 1 | $17 |
| Cardiovascular Systems Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GORE TAG Thoracic Branch Endoprosthesis$1,062
- FLOWTRIEVER CATHETER, S$1,006
- CT THROMBECTOMY SYSTEM KIT$1,006
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$735
- ENROUTE Transcarotid Neuroprotection System$599
- ENROUTE Transcarotid Stent$449
- GORE EXCLUDER AAA Endoprosthesis$330
- ENDOCROSS Device$299
- Torus Stent Graft System$299
- Lutonix Drug Coated Balloon$253
- Grafts$179
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$150
- (6576) Laser serv and other$148
- IMPEDE EMBOLIZATION PLUG$148
- ENHANCE Transcarotid Peripheral Access Kit$141
- ENROUTE .014 Guidewire$141
- Zynrelef$125
- XARELTO$125
- HawkOne$112
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$110
How this compares
$9,717 in reported general payments places this provider in the 60th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 27 | $35,068 |
| XareltoRivaroxaban | 33 | $32,417 |
| ClopidogrelClopidogrel Bisulfate | 111 | $1,149 |
| Gabapentin | 27 | $547 |
| Cilostazol | 11 | $228 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $831 | $32,41733 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 347 vascular surgery providers in Texas.
Other vascular surgery in San Antonio
- William EnglishSan Antonio$194K
- Lucas Ferrer CardonaSan Antonio$141K
- Nessa MillerSan Antonio$41K
- Lyssa OchoaSan Antonio$39K
- Ashton LeeSan Antonio$35K
- Andrew NagySan Antonio$35K
- Gregory PearlDallas$2.3M
- Mazin FotehAustin$1.6M
- Alan LumsdenHouston$742K
- Stephen HohmannDallas$499K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.